Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 7/2008

01-10-2008 | ORIGINAL PAPER

Insight, cognitive dysfunction and symptomatology in schizophrenia

Authors: Luciana C. Monteiro, Vanessa A. Silva, Mario R. Louzã

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 7/2008

Login to get access

Abstract

Lack of insight is frequent in schizophrenia and usually influences negatively both patient’s treatment and prognosis. This study aimed to investigate the relationship between insight, symptomatology and cognitive dysfunctions in schizophrenia using the PANSS five-factor model (modified from Gaag et al. in Schizophr Res 85:280–287, 2006). Forty patients diagnosed with chronic schizophrenia (DSM-IV) were evaluated with the scale to assess unawareness of mental disorder (SUMD), the PANSS and a neuropsychological battery. Spearman correlation and linear regression analyses were performed to investigate the relationship between clinical, neurocognitive and insight measures. The SUMD current and past awareness of symptoms score showed a correlation with WCST indices (correct answers and non-persevering errors). The negative and disorganization factor of the PANSS showed a positive correlation with current and past awareness of symptoms. However, when submitted to a linear regression model only the disorganization factor emerged as significant contributor for insight. Considering that the core items of the “disorganization factor” of the PANSS are related to cognition (e.g., poor attention, difficult in abstract thinking), insight is associated cognitive symptoms although no direct relationship between insight and neuropsychological tests was observed.
Literature
1.
go back to reference Aleman A, Agrawal N, Morgan KD, David AS (2006) Insight in psychosis and neuropsychological function. Br J Psychiatry 189:204–212PubMedCrossRef Aleman A, Agrawal N, Morgan KD, David AS (2006) Insight in psychosis and neuropsychological function. Br J Psychiatry 189:204–212PubMedCrossRef
2.
go back to reference Amador XF, David HS, Yale SA, Gorman JM (1991) Awareness of illness in schizophrenia. Schizophr Bull 17:113–131PubMed Amador XF, David HS, Yale SA, Gorman JM (1991) Awareness of illness in schizophrenia. Schizophr Bull 17:113–131PubMed
3.
go back to reference Amador XF, Gorman JM (1998) Psychopathologic domains and insight in schizophrenia. Psych Clin North Am 21:27–41CrossRef Amador XF, Gorman JM (1998) Psychopathologic domains and insight in schizophrenia. Psych Clin North Am 21:27–41CrossRef
4.
go back to reference American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). APA, Washington, DC American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). APA, Washington, DC
5.
go back to reference Benton AL, Hamsher KD, Varney NR, Spreen O (1994) Contributions to neuropsychology assessment: a clinical manual. Oxford University Press, New York Benton AL, Hamsher KD, Varney NR, Spreen O (1994) Contributions to neuropsychology assessment: a clinical manual. Oxford University Press, New York
6.
go back to reference Chaves AC, Shirakawa I (2000) Escalas das síndromes negativa e positiva – e seu uso no Brasil. In: Gorenstein C, Andrade LHSG, Zuardi AW (eds) Escalas de avaliação clínica em psiquiatria e psicofarmacologia. Editora Lemos, São Paulo, pp 219–224 Chaves AC, Shirakawa I (2000) Escalas das síndromes negativa e positiva – e seu uso no Brasil. In: Gorenstein C, Andrade LHSG, Zuardi AW (eds) Escalas de avaliação clínica em psiquiatria e psicofarmacologia. Editora Lemos, São Paulo, pp 219–224
7.
go back to reference Collins AA, Remington GJ, Coulter K, Birkett K (1997) Insight, neurocognitive function and symptom clusters in chronic schizophrenia. Schizophr Res 27:37–44PubMedCrossRef Collins AA, Remington GJ, Coulter K, Birkett K (1997) Insight, neurocognitive function and symptom clusters in chronic schizophrenia. Schizophr Res 27:37–44PubMedCrossRef
8.
go back to reference Conners K (2002) CPT-II—continuous performance test II. Multi-Health Systems Inc, Conners K (2002) CPT-II—continuous performance test II. Multi-Health Systems Inc,
9.
go back to reference Cuesta MJ, Peralta V (1994) Lack of insight in schizophrenia. Schizophr Bull 20:359–366PubMed Cuesta MJ, Peralta V (1994) Lack of insight in schizophrenia. Schizophr Bull 20:359–366PubMed
10.
go back to reference Cuesta MJ, Peralta V, Zarzuela A, Zandio M (2006) Insight dimensions and cognitive function in psychosis: a longitudinal study. BMC Psychiatry 6:26PubMedCrossRef Cuesta MJ, Peralta V, Zarzuela A, Zandio M (2006) Insight dimensions and cognitive function in psychosis: a longitudinal study. BMC Psychiatry 6:26PubMedCrossRef
11.
go back to reference Donohoe G, Corvin A, Robertson IH (2005) Are the cognitive deficits associated with impaired insight in schizophrenia specific to executive task performance? J Nerv Ment Dis 193:803–808PubMedCrossRef Donohoe G, Corvin A, Robertson IH (2005) Are the cognitive deficits associated with impaired insight in schizophrenia specific to executive task performance? J Nerv Ment Dis 193:803–808PubMedCrossRef
12.
13.
go back to reference Fiss N, Chaves AC (2005) Translation, adaptation and reliability study of the scale to assess unawareness of mental disorder—SUMD. Rev Br Psiquiatria 27:143–145 Fiss N, Chaves AC (2005) Translation, adaptation and reliability study of the scale to assess unawareness of mental disorder—SUMD. Rev Br Psiquiatria 27:143–145
14.
go back to reference Gaag M, Hoffman T, Remijsen M, Hijman R, Haan L, Meijel B, Harten PN, Valmaggia L, Hert M, Cuijpers A, Wiersma D (2006) The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model. Schizophr Res 85:280–287PubMedCrossRef Gaag M, Hoffman T, Remijsen M, Hijman R, Haan L, Meijel B, Harten PN, Valmaggia L, Hert M, Cuijpers A, Wiersma D (2006) The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model. Schizophr Res 85:280–287PubMedCrossRef
15.
go back to reference Goodman C, Knoll G, Isakov V, Silver H (2005) Insight into illness in schizophrenia. Compr Psychiatry 46:284–290PubMedCrossRef Goodman C, Knoll G, Isakov V, Silver H (2005) Insight into illness in schizophrenia. Compr Psychiatry 46:284–290PubMedCrossRef
16.
go back to reference Heaton RK (2003) WCST-64: computer version 2—research edition. Psycological Assessment Resources, Odessa Heaton RK (2003) WCST-64: computer version 2—research edition. Psycological Assessment Resources, Odessa
17.
go back to reference Laroi F, Fannemel M, Ronneberg U, Flekkoy K, Opjordsmoen S, Dullerud R, Haakonsen M (2000) Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res Neuroimage Sect 100:49–58CrossRef Laroi F, Fannemel M, Ronneberg U, Flekkoy K, Opjordsmoen S, Dullerud R, Haakonsen M (2000) Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res Neuroimage Sect 100:49–58CrossRef
18.
go back to reference Laws KR (1999) A meta-analytic review of Wisconsin card sort studies in schizophrenia: general intellectual deficit? Cogn Neuropsychiatry 4(1):1–35CrossRefPubMed Laws KR (1999) A meta-analytic review of Wisconsin card sort studies in schizophrenia: general intellectual deficit? Cogn Neuropsychiatry 4(1):1–35CrossRefPubMed
19.
go back to reference Lysaker P, Bell M (1994) Insight and cognitive impairment in schizophrenia: performance on repeated administrations of the Wisconsin card sorting test. J Nerv Ment Dis 182:656–660PubMed Lysaker P, Bell M (1994) Insight and cognitive impairment in schizophrenia: performance on repeated administrations of the Wisconsin card sorting test. J Nerv Ment Dis 182:656–660PubMed
20.
go back to reference Lysaker PH, Bell MD, Bryson G, Kaplan E (1998) Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand 97:297–301PubMedCrossRef Lysaker PH, Bell MD, Bryson G, Kaplan E (1998) Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand 97:297–301PubMedCrossRef
21.
go back to reference Lysaker PH, Bryson GJ, Lancaster RS, Evans JD, Bell MD (2002) Insight in schizophrenia: associations with executive function and coping style. Schizophr Res 59:41–47CrossRef Lysaker PH, Bryson GJ, Lancaster RS, Evans JD, Bell MD (2002) Insight in schizophrenia: associations with executive function and coping style. Schizophr Res 59:41–47CrossRef
22.
go back to reference Maccabe R, Quayle E, Beirne AD, Duane MMA (2002) Insight, global neuropsychological functioning, and symptomatology in chronic schizophrenia. J Nerv Ment Dis 190:519–525CrossRef Maccabe R, Quayle E, Beirne AD, Duane MMA (2002) Insight, global neuropsychological functioning, and symptomatology in chronic schizophrenia. J Nerv Ment Dis 190:519–525CrossRef
23.
go back to reference McEvoy JP, Hartman M, Gottlieb D, Godwin S, Apperson LJ, Wilson W (1996) Common sense, insight, and neuropsychological test performance in schizophrenia patients. Schizophr Bull 22:635–641PubMed McEvoy JP, Hartman M, Gottlieb D, Godwin S, Apperson LJ, Wilson W (1996) Common sense, insight, and neuropsychological test performance in schizophrenia patients. Schizophr Bull 22:635–641PubMed
24.
go back to reference Medalia A, Lim RW (2004) Self-awareness of cognitive unctioning in schizophrenia. Schizophr Res 71:331–338PubMedCrossRef Medalia A, Lim RW (2004) Self-awareness of cognitive unctioning in schizophrenia. Schizophr Res 71:331–338PubMedCrossRef
25.
go back to reference Mintz AR, Dobson KS, Romney DM (2003) Insight in schizophrenia: a meta-analysis. Schizophr Res 61:75–88PubMedCrossRef Mintz AR, Dobson KS, Romney DM (2003) Insight in schizophrenia: a meta-analysis. Schizophr Res 61:75–88PubMedCrossRef
26.
go back to reference Mohamed S, Fleming S, Penn DL, Spaulding W (1999) Insight in schizophrenia: its relationship to measures of executive functions. J Nerv Ment Dis 187:525–531PubMedCrossRef Mohamed S, Fleming S, Penn DL, Spaulding W (1999) Insight in schizophrenia: its relationship to measures of executive functions. J Nerv Ment Dis 187:525–531PubMedCrossRef
27.
go back to reference Reitan RM (1958) Validity of the trail making test as a indicator of organic brain damage. Percept Motor Skills 8:271–276 Reitan RM (1958) Validity of the trail making test as a indicator of organic brain damage. Percept Motor Skills 8:271–276
28.
go back to reference Rey A. Teste de cópia e de reprodução de memória de figuras geométricas complexas. Adaptação Brasileira. Tradução: Oliveira MS (1998; 1999) Casa do Psicólogo, São Paulo Rey A. Teste de cópia e de reprodução de memória de figuras geométricas complexas. Adaptação Brasileira. Tradução: Oliveira MS (1998; 1999) Casa do Psicólogo, São Paulo
29.
go back to reference Rossell SL, Coakes J, Shapleske J, Woodruff PWR, David AS (2003) Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 33:111–119PubMedCrossRef Rossell SL, Coakes J, Shapleske J, Woodruff PWR, David AS (2003) Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 33:111–119PubMedCrossRef
30.
go back to reference Sevy S, Nathanson K, Visweswaraiah H, Amador X (2004) The relationship between insight and symptoms in schizophrenia. Comp Psychiatry 45:16–19CrossRef Sevy S, Nathanson K, Visweswaraiah H, Amador X (2004) The relationship between insight and symptoms in schizophrenia. Comp Psychiatry 45:16–19CrossRef
31.
go back to reference Smith TE, Hull JW, Goodman M, Hedayat-Harris A, Wisson DF, Israel LM, Munich RL (1999) The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 187:102–108PubMedCrossRef Smith TE, Hull JW, Goodman M, Hedayat-Harris A, Wisson DF, Israel LM, Munich RL (1999) The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 187:102–108PubMedCrossRef
32.
go back to reference Smith TE, Hull JW, Israel LM, Willson DF (2000) Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Schizophr Bull 26:193–200PubMed Smith TE, Hull JW, Israel LM, Willson DF (2000) Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Schizophr Bull 26:193–200PubMed
33.
go back to reference Spreen O, Etrauss E (1998) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, New York Spreen O, Etrauss E (1998) A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press, New York
34.
go back to reference Startup M (1996) Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship. Psychol Med 26:1277–1281PubMedCrossRef Startup M (1996) Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship. Psychol Med 26:1277–1281PubMedCrossRef
35.
go back to reference Subotnik KL, Nuechterlein KH, Irzhevsky V, Kitchen CM, Woo SM, Mintz J (2005) Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem? Schizophr Res 75:147–157PubMedCrossRef Subotnik KL, Nuechterlein KH, Irzhevsky V, Kitchen CM, Woo SM, Mintz J (2005) Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem? Schizophr Res 75:147–157PubMedCrossRef
36.
go back to reference Wechsler D (1981) Wechsler intelligence scale—revised. Psychological Corporation, New York Wechsler D (1981) Wechsler intelligence scale—revised. Psychological Corporation, New York
37.
go back to reference Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667PubMedCrossRef Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667PubMedCrossRef
38.
go back to reference Young DA, Zakzanis KK, Bailey C, Davila R, Griese J, Sartory G, Thom A (1998) Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease. J Nerv Ment Dis 186:44–50PubMedCrossRef Young DA, Zakzanis KK, Bailey C, Davila R, Griese J, Sartory G, Thom A (1998) Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease. J Nerv Ment Dis 186:44–50PubMedCrossRef
Metadata
Title
Insight, cognitive dysfunction and symptomatology in schizophrenia
Authors
Luciana C. Monteiro
Vanessa A. Silva
Mario R. Louzã
Publication date
01-10-2008
Publisher
D. Steinkopff-Verlag
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 7/2008
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-008-0809-8

Other articles of this Issue 7/2008

European Archives of Psychiatry and Clinical Neuroscience 7/2008 Go to the issue